Table 1 shows 2030 costs and four key costs drivers

Next →

Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe

19 July 202319 July 2023 Camila Camara

Deployment of Artificial Intelligence is key to European competitiveness

21 October 2020 Camila Camara

Bridging the gap between advanced therapy development and patient access in Europe: regulatory, clinical and translational challenges

8 July 2026 Camila Camara

New Issue

Brussels Sustainability Club

We use cookies and other technologies to customize your experience, perform analytics and deliver personalized advertising on our sites and newsletters and across the Internet based on your interests. By clicking “I agree”, you consent to the use by us and our third-party partners of cookies and data gathered from your use of our platforms.

You May Also Like

Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe

Deployment of Artificial Intelligence is key to European competitiveness

Bridging the gap between advanced therapy development and patient access in Europe: regulatory, clinical and translational challenges